HBP.TO
Helix Biopharma Corp
Price:  
0.23 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO Relative Valuation

-101.1%
Upside

As of 2024-06-22, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.23 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -101.1%.

The range of the Relative Valuation is (0.00) - (0.01) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 0.1x - 0.3x 0.1x
Forward P/E multiples 0.1x - 0.3x 0.1x
Fair Price (0.00) - (0.01) (0.00)
Upside -100.9% - -103.2% -101.1%
0.23 CAD
Stock Price
(0.00) CAD
Fair Price

HBP.TO Relative Valuation - Historical P/E Data

Date P/E
2024-06-21 -9.75
2024-06-18 -9.35
2024-06-14 -9.75
2024-06-13 -10.36
2024-06-11 -10.56
2024-06-10 -8.74
2024-06-07 -10.97
2024-06-06 -8.94
2024-06-04 -9.75
2024-05-30 -8.53
2024-05-28 -8.33
2024-05-24 -8.33
2024-05-22 -8.53
2024-05-21 -8.53
2024-05-14 -8.53
2024-05-13 -9.35
2024-05-10 -9.35
2024-05-09 -9.35
2024-05-08 -9.35
2024-05-06 -8.94
2024-05-03 -8.33
2024-05-02 -8.53
2024-05-01 -8.94
2024-04-30 -8.94
2024-04-29 -8.94
2024-04-26 -8.53
2024-04-25 -8.53
2024-04-24 -7.92
2024-04-23 -7.72
2024-04-22 -7.72
2024-04-17 -7.11
2024-04-15 -8.13
2024-04-11 -7.52
2024-04-10 -7.52
2024-04-08 -7.31
2024-04-05 -7.52
2024-04-02 -7.31
2024-04-01 -7.31
2024-03-27 -7.31
2024-03-26 -7.31